Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis
Launched by UNIVERSITY HOSPITAL, GHENT · Jul 26, 2013
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Acute onset of ARDS criteria on chest X-ray or CT scan
- • Moderate (PaO2/ FiO2 \<200) or severe ARDS (PaO2/ FiO2 \<100) (FiO2: fraction of inspired oxygen)
- • Respiratory acidosis with pH\< 7,25,
- • With plateau pressure of 28cmH20 or higher,
- Exclusion criteria:
- • \<18 years of age
- • Pregnancy
- • Obesity with BMI\> 30
- • Contraindication for anticlotting therapy
- • Chest wall abnormalities
- • No presumed consent of representatives
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Trial Officials
Harlinde Peperstraete, MD
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials